NCT05016804View on ClinicalTrials.gov

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell IV Infusion for Systemic Sclerosis

PHASE1RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 4, 2022

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2026

Conditions
Systemic Sclerosis
Interventions
BIOLOGICAL

AlloRx

cultured allogeneic adult umbilical cord derived mesenchymal stem cells

Trial Locations (2)

Unknown

RECRUITING

Medical Surgical Associates Center, St John's

RECRUITING

Center for Investigation in Tissue Engineering and Cellular Therapy, Buenos Aires

All Listed Sponsors
lead

The Foundation for Orthopaedics and Regenerative Medicine

OTHER